Anticancer Research is an international journal designed to rapidly publish original papers and reviews on experimental and clinical cancer research. Anticancer Research was established in 1981 by J.G. Delinasios. In this site you may find information concerning the editorial board, editorial policy, subscriptions, submission of manuscripts, online open articles, advertising, special offers for authors and a current list of accepted manuscripts.
Announcement – Call for Papers
Special Issue of ANTICANCER RESEARCH 2021 on NEW ANTICANCER AGENTS
A. Experimental studies on “Νew Anticancer Agents”
1. SYNTHESIS AND EVALUATION IN VITRO AND IN VIVO
2. MECHANISM OF ACTION
3. REVERSAL OF RESISTANCE TO ANTICANCER AGENTS
4. ONCOLYTIC VIRUSES
B. Clinical studies on “New Anticancer Agents”
2. CLINICAL TRIALS
3. COMBINATION CHEMOTHERAPY
4. IMMUNOTHERAPEUTIC AGENTS
5. NEW METHODOLOGIES IN DRUG DELIVERY
Deadline for submission of original and review articles: October 20, 2021
Publication date: December 2021
Dr. George J. Delinasios, e-mail: firstname.lastname@example.org
Impact factor (2020): 2.480
Total cites: 25,656
Library Recommendation Form
Please print and complete this form. Send or give the completed form to your librarian to recommend Anticancer Research.
Your link to essential information on cancer research published in the last 40 years.
ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389